USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
Zymera Corporation
Address:
5941 OPTICAL COURT
SAN JOSE, CA 95138-
Phone:
(650) 515-7897
URL:
N/A
EIN:
721589494
DUNS:
171080885
Number of Employees:
5
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $199,993.00 2
SBIR Phase II $1,597,661.00 2
STTR Phase I $150,000.00 1

Award List:

SBIR Phase I: Bioluminescence Resonance Energy Transfer Assays for Clinical Chemistry

Award Year / Program / Phase:
2007 / SBIR / Phase I
Award Amount:
$99,993.00
Agency:
NSF
Principal Investigator:
Abstract:
This Small Business Innovation Research (SBIR) Phase I research project aims to develop a point-of-care assay for creatine kinase, an important toxicity biomarker, to screen for adverse drug reactions (ADRs) using whole blood. The assay will utilize bioluminescent resonance energy transfer (BRET)… More

STTR Phase I: Non-Toxic Nanoparticles for BRET-Based Molecular Imaging

Award Year / Program / Phase:
2009 / STTR / Phase I
Award Amount:
$150,000.00
Agency:
NSF
Principal Investigator:
Research Institution:
Carnegie-Mellon University
RI Contact:
Marcel Bruchez
Abstract:
This award is funded under the American Recovery and Reinvestment Act of 2009 (Public Law 111-5). This Small Business Technology Transfer (STTR) Phase I project will result in the demonstration of non-toxic multi-modality nanoparticle-based molecular probes for in vivo imaging. The objective of the… More

SBIR Phase I: Bioluminescence Resonance Energy Transfer Probes for Molecular Imaging

Award Year / Program / Phase:
2009 / SBIR / Phase I
Award Amount:
$100,000.00
Agency:
NSF
Principal Investigator:
Abstract:
This Small Business Innovation Research (SBIR) Phase I project will demonstrate the detection of an established target in cancer diagnosis and treatment using new targeted Bioluminescence Resonance Energy Transfer to Quantum Dots (BRET-QD) technology. BRET-QD offers substantial advantages over… More

SBIR Phase II: Bioluminescence Resonance Energy Transfer Probes for Molecular Imaging

Award Year / Program / Phase:
2010 / SBIR / Phase II
Award Amount:
$600,296.00
Agency:
NSF
Principal Investigator:
Abstract:
This Small Business Innovation Research (SBIR) Phase II project will demonstrate the production of robust, versatile probes based on Bioluminescence Resonance Energy Transfer to Quantum Dots (BRET-Qdot

IGF::OT::IGF OTHER FUNCTIONS RandD- MEDICAL: BIOMEDICAL (BASIC RESEARCH) SBIR PHASE II TOPIC NO. 266 PROJECT ENTITLED: HOMOGENEOUS NANO PARTICLE - BASED ASSAYS FOR PROTEASE DETECTION

Award Year / Program / Phase:
2012 / SBIR / Phase II
Award Amount:
$997,365.00
Agency:
HHS
Principal Investigator:
Daniel Sobek – 650-515-7897
Abstract:
The objectives of the Phase II project are to further develop a new protease detection technology platform with versatile application capabilities (in vitro and in vivo) including cancer applications: detection of two markers within a common signaling pathway to determine the prognosis of ovarian… More